- Home
- SNGX vs GSUN Comparison
SNGX vs GSUN Comparison
Compare SNGX & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- GSUN
- Stock Information
- Founded
- SNGX 1987
- GSUN 1997
- Country
- SNGX United States
- GSUN China
- Employees
- SNGX N/A
- GSUN N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- GSUN Other Consumer Services
- Sector
- SNGX Health Care
- GSUN Real Estate
- Exchange
- SNGX Nasdaq
- GSUN Nasdaq
- Market Cap
- SNGX 6.5M
- GSUN 6.4M
- IPO Year
- SNGX 1987
- GSUN 2022
- Fundamental
- Price
- SNGX $1.37
- GSUN $2.38
- Analyst Decision
- SNGX
- GSUN
- Analyst Count
- SNGX 0
- GSUN 0
- Target Price
- SNGX N/A
- GSUN N/A
- AVG Volume (30 Days)
- SNGX 147.3K
- GSUN 60.6K
- Earning Date
- SNGX 08-08-2025
- GSUN 08-01-2025
- Dividend Yield
- SNGX N/A
- GSUN N/A
- EPS Growth
- SNGX N/A
- GSUN N/A
- EPS
- SNGX N/A
- GSUN N/A
- Revenue
- SNGX $2,342.00
- GSUN $10,159,020.00
- Revenue This Year
- SNGX N/A
- GSUN N/A
- Revenue Next Year
- SNGX N/A
- GSUN N/A
- P/E Ratio
- SNGX N/A
- GSUN N/A
- Revenue Growth
- SNGX N/A
- GSUN 65.04
- 52 Week Low
- SNGX $1.31
- GSUN $2.23
- 52 Week High
- SNGX $14.83
- GSUN $8.94
- Technical
- Relative Strength Index (RSI)
- SNGX 23.71
- GSUN 26.08
- Support Level
- SNGX $1.31
- GSUN $2.50
- Resistance Level
- SNGX $1.95
- GSUN $2.88
- Average True Range (ATR)
- SNGX 0.07
- GSUN 0.12
- MACD
- SNGX -0.05
- GSUN -0.07
- Stochastic Oscillator
- SNGX 9.56
- GSUN 15.43
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.